Consensus Novonesis A/S

Equities

NSIS B

DK0060336014

Market Closed - Nasdaq Copenhagen 10:59:45 2024-04-25 am EDT 5-day change 1st Jan Change
384.7 DKK -0.82% Intraday chart for Novonesis A/S -0.05% +3.66%

Evolution of the average Target Price on Novonesis A/S

Price target over the last 5 years

History of analyst recommendation changes

75eb03bb6f82fa6ab2f436b212137.PC5wpoSPWLYMlXdkmFFwhw4Pef3Lc0_C0y_VvibX-HE.T0Iqkez7FsM-4jkN3TdJ6EljKbGAFhCnoUf4-U6tiAtJGDfc9b4M_nusFA~0ff257cfa90eca665c9b1067ea537116
NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments Alphavalue
NOVOZYMES : Q3 23: Stable volume growth underpinned by a recovery in key segments Alphavalue
NOVOZYMES : Q2 23: Broad-based weakness leads to a guidance downgrade Alphavalue
Berenberg Innovation Conference FA
NOVOZYMES : BioEnergy surprise drives Q1 23 momentum Alphavalue
NOVOZYMES : EPS cut (2022: +2.3%, 2023: -14.3%) Alphavalue
NOVOZYMES : Q4 22: solid top-line momentum even as profits fall short Alphavalue
NOVOZYMES : Novozymes/Chr. Hansen: Pricey ‘growth’ punt? Alphavalue
European shares slip on fears over rising China COVID cases, await rate decisions RE
Berenberg European Conference FA
Roche’s Alzheimer’s failure has sector-wide implications Alphavalue
NOVOZYMES : Q3 22: Not as rosy as it looks Alphavalue
NOVOZYMES : Solid Q2; FY 22 top-line guidance looks conservative Alphavalue
BNPP Exane European CEO Conference FA
Berenberg USA Conference FA
NOVOZYMES : Ex-household care, strong start to FY 22 Alphavalue
NOVOZYMES : Q4 21: household weakness and inflation in focus Alphavalue
Berenberg European Conference FA
NOVOZYMES : Strong Q3 21; Household care ‘only’ sore spot Alphavalue
ANALYST RECOMMENDATIONS : Asos, Avis Budget, Meritage Homes, Kansas City Southern, UPS... Our Logo
NOVOZYMES : FY21 guidance appears soft following strong Q221 Alphavalue
TODAY'S ANALYST RECOMMENDATIONS : Dollar General, ENI, Infineon... Our Logo
NOVOZYMES : Strong Q1 21 led by key growth drivers Alphavalue
Exane Consumer Ingredients Conference FA
NOVOZYMES : Muted end (Q4) to a volatile year (2020) Alphavalue
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
387.9 DKK
Average target price
430.9 DKK
Spread / Average Target
+11.08%
High Price Target
500 DKK
Spread / Highest target
+28.90%
Low Price Target
350 DKK
Spread / Lowest Target
-9.77%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Novonesis A/S

alphavalue Virendra Chauhan
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
  1. Stock Market
  2. Equities
  3. NSIS B Stock
  4. Consensus Novonesis A/S